Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103029290> ?p ?o ?g. }
- W3103029290 abstract "Programmed death protein 1 (PD-1) interaction with PD-L1 deliver immunosuppressive environment for tumor growth, and its blockade with directed monoclonal antibodies (anti-PD-1/anti-PD-L1) has shown remarkable clinical outcome. Lately, their soluble counterparts, sPD-1 and sPD-L1, have been detected in plasma, and elevated levels have been associated with advanced disease, clinical stages, and worst prognosis for cancer patients. Elevated plasma levels of sPD-L1 have been correlated with worst prognosis in several studies and has displayed a persistent outlook. On the other hand, sPD-1 levels have been inconsistent in their predictive and prognostic ability. Pretherapeutic higher sPD-1 plasma levels have shown to predict advanced disease state and to a lesser extent worst prognosis. Any increase in sPD-1 plasma level post therapeutically have been correlated with improved survival for various cancers. In vitro and in vivo studies have shown sPD-1 ability to bind PD-L1 and PD-L2 and block PD-1/PD-L1 interaction. Local delivery of sPD-1 in cancer tumor microenvironment through local gene therapy have demonstrated an increase in tumor specific CD8+ T cell immunity and tumor growth reduction. It had also exhibited enhancement of T cell immunity induced by vaccination and other gene therapeutic agents. Furthermore, it may also lessen the inhibitory effect of circulating sPD-L1 and enhance the effects of mAb based immunotherapy. In this review, we highlight various aspects of sPD-1 role in cancer prediction, prognosis, and anti-cancer immunity, as well as, its therapeutic value for local gene therapy or systemic immunotherapy in blocking the PD-1 and PD-L1 checkpoint interactions." @default.
- W3103029290 created "2020-11-23" @default.
- W3103029290 creator A5001960617 @default.
- W3103029290 creator A5043251239 @default.
- W3103029290 creator A5081383244 @default.
- W3103029290 creator A5082832139 @default.
- W3103029290 creator A5086533374 @default.
- W3103029290 date "2020-11-19" @default.
- W3103029290 modified "2023-10-18" @default.
- W3103029290 title "Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy" @default.
- W3103029290 cites W1519739419 @default.
- W3103029290 cites W1538902372 @default.
- W3103029290 cites W1539328666 @default.
- W3103029290 cites W1564628728 @default.
- W3103029290 cites W1575758488 @default.
- W3103029290 cites W1630171124 @default.
- W3103029290 cites W1789997511 @default.
- W3103029290 cites W1907001600 @default.
- W3103029290 cites W1915829159 @default.
- W3103029290 cites W1949743561 @default.
- W3103029290 cites W1965999622 @default.
- W3103029290 cites W1966676297 @default.
- W3103029290 cites W1976065095 @default.
- W3103029290 cites W1976105607 @default.
- W3103029290 cites W1977759217 @default.
- W3103029290 cites W1978358283 @default.
- W3103029290 cites W1982862191 @default.
- W3103029290 cites W1984899475 @default.
- W3103029290 cites W1986104642 @default.
- W3103029290 cites W1986354050 @default.
- W3103029290 cites W1988769784 @default.
- W3103029290 cites W1992372351 @default.
- W3103029290 cites W1993686673 @default.
- W3103029290 cites W1994257755 @default.
- W3103029290 cites W1996863944 @default.
- W3103029290 cites W1997241837 @default.
- W3103029290 cites W2000307261 @default.
- W3103029290 cites W2000609012 @default.
- W3103029290 cites W2002246446 @default.
- W3103029290 cites W2007529060 @default.
- W3103029290 cites W2008034791 @default.
- W3103029290 cites W2008534009 @default.
- W3103029290 cites W2008618151 @default.
- W3103029290 cites W2012315955 @default.
- W3103029290 cites W2015119709 @default.
- W3103029290 cites W2018478752 @default.
- W3103029290 cites W2020766415 @default.
- W3103029290 cites W2023165988 @default.
- W3103029290 cites W2026223086 @default.
- W3103029290 cites W2027097409 @default.
- W3103029290 cites W2028368510 @default.
- W3103029290 cites W2028376975 @default.
- W3103029290 cites W2032818767 @default.
- W3103029290 cites W2034751554 @default.
- W3103029290 cites W2038526922 @default.
- W3103029290 cites W2039096179 @default.
- W3103029290 cites W2039395562 @default.
- W3103029290 cites W2048810850 @default.
- W3103029290 cites W2048913149 @default.
- W3103029290 cites W2051083170 @default.
- W3103029290 cites W2054076973 @default.
- W3103029290 cites W2055981904 @default.
- W3103029290 cites W2057782225 @default.
- W3103029290 cites W2060417878 @default.
- W3103029290 cites W2061252374 @default.
- W3103029290 cites W2061467047 @default.
- W3103029290 cites W2066002010 @default.
- W3103029290 cites W2069800089 @default.
- W3103029290 cites W2073580835 @default.
- W3103029290 cites W2074546881 @default.
- W3103029290 cites W2081260856 @default.
- W3103029290 cites W2085129277 @default.
- W3103029290 cites W2094548766 @default.
- W3103029290 cites W2095826194 @default.
- W3103029290 cites W2097514222 @default.
- W3103029290 cites W2098205979 @default.
- W3103029290 cites W2098694739 @default.
- W3103029290 cites W2100039832 @default.
- W3103029290 cites W2100412095 @default.
- W3103029290 cites W2101094698 @default.
- W3103029290 cites W2103532863 @default.
- W3103029290 cites W2104350866 @default.
- W3103029290 cites W2104643966 @default.
- W3103029290 cites W2104732141 @default.
- W3103029290 cites W2104762259 @default.
- W3103029290 cites W2105697998 @default.
- W3103029290 cites W2106760898 @default.
- W3103029290 cites W2110064348 @default.
- W3103029290 cites W2110305039 @default.
- W3103029290 cites W2118471749 @default.
- W3103029290 cites W2119993617 @default.
- W3103029290 cites W2121498145 @default.
- W3103029290 cites W2123918574 @default.
- W3103029290 cites W2127733313 @default.
- W3103029290 cites W2129629929 @default.
- W3103029290 cites W2130506153 @default.
- W3103029290 cites W2138062457 @default.
- W3103029290 cites W2141713160 @default.
- W3103029290 cites W2143161597 @default.
- W3103029290 cites W2144082786 @default.